Alpha Tau Medical Ltd. (NASDAQ:DRTSW – Get Free Report)’s stock price was up 16.7% on Monday . The stock traded as high as $0.38 and last traded at $0.35. Approximately 74,167 shares were traded during mid-day trading, an increase of 77% from the average daily volume of 41,982 shares. The stock had previously closed at $0.30.
Alpha Tau Medical Stock Performance
The business’s 50 day simple moving average is $0.30 and its 200-day simple moving average is $0.24.
Alpha Tau Medical Company Profile
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. The company's Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; preclinical or pending clinical studies for brain and other cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others.
Further Reading
- Five stocks we like better than Alpha Tau Medical
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Nebius Group: NVIDIA’s Investment Sparks All-Time Highs
- What is the Dow Jones Industrial Average (DJIA)?
- SoFi Stock Rallying Strong in the Last 5 Days—What’s Driving It?
- Where Do I Find 52-Week Highs and Lows?
- Intel Surges on M&A Talks: Rally Beginning or Just a Headfake?
Receive News & Ratings for Alpha Tau Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alpha Tau Medical and related companies with MarketBeat.com's FREE daily email newsletter.
